Category survey

Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer disease

Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Treatment of psychosis and agitation in Alzheimers disease

Treatment of psychosis and agitation in Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Cognitive and Aerobic Resilience for the Brain

Cognitive and Aerobic Resilience for the Brain Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

MIND: An RCT of care coordination for community-living persons with dementia

MIND: An RCT of care coordination for community-living persons with dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

MIND Diet Intervention to Prevent Alzheimers Disease

MIND Diet Intervention to Prevent Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimers Symptomatic Expression: The INCREASE study

INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimers Symptomatic Expression: The INCREASE study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment

Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Advancing Geriatrics Infrastructure & Network Growth (Admin Supplement): Deprescribing Potential for Older Adults with Alzheimers Disease and Cognitive Impairment

Advancing Geriatrics Infrastructure & Network Growth (Admin Supplement): Deprescribing Potential for Older Adults with Alzheimers Disease and Cognitive Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Memory Care Partner

Memory Care Partner Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Novel Detection of Early Cognitive and Functional Impairment in the Elderly

Novel Detection of Early Cognitive and Functional Impairment in the Elderly Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Cardiac function as a mechanism for maladaptive brain aging

Cardiac function as a mechanism for maladaptive brain aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings

Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Investigating the role of bvFTD-affected networks in socioemotional behavior

Investigating the role of bvFTD-affected networks in socioemotional behavior Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Return of Amyloid Imaging Research Results in MCI

Return of Amyloid Imaging Research Results in MCI Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Social Support Aid for People with Dementia

Social Support Aid for People with Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Rhythm and Timing Exercises for Cerebral Vascular Disease in American Indians

Rhythm and Timing Exercises for Cerebral Vascular Disease in American Indians Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Memory Matters: A Mobile Aid to Stimulate Reminiscing in Persons with Memory Loss

Memory Matters: A Mobile Aid to Stimulate Reminiscing in Persons with Memory Loss Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

AD Pilot Clinical Trials: Spatiotemporal Brain ERP Measures

AD Pilot Clinical Trials: Spatiotemporal Brain ERP Measures Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Function and Behavior Focused Care for Nursing Home Residents with Dementia

Function and Behavior Focused Care for Nursing Home Residents with Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Escitalopram for Agitation in Alzheimer Disease

Escitalopram for Agitation in Alzheimer Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimers disease (AD)

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimers disease (AD) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Actigraphic assessment of sleep quality in the A4 trial

Actigraphic assessment of sleep quality in the A4 trial Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Software Platform for Analyzing Alzheimers and Parkinsons fMRI Connectomes

Software Platform for Analyzing Alzheimers and Parkinsons fMRI Connectomes Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Effects of physical activity on brain function and network connectivity in MCI

Effects of physical activity on brain function and network connectivity in MCI Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Processing Speed Training to Preserve Driving and Functional Competencies in MCI

Processing Speed Training to Preserve Driving and Functional Competencies in MCI Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Alzheimers Disease Neuroimaging Initiative

Alzheimers Disease Neuroimaging Initiative Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Conversational engagement as a means to delay onset AD: Phase II

Conversational engagement as a means to delay onset AD: Phase II Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk

Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

The A3 Study: Ante-Amyloid Prevention of Alzheimers disease

The A3 Study: Ante-Amyloid Prevention of Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Problem Adaptation Therapy for Mild Cognitive Impairment with Depression

Problem Adaptation Therapy for Mild Cognitive Impairment with Depression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimers disease.

A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimers disease. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Phase 1b first-in-patient safety trial for CT1812, a novel Alzheimers synaptic protection therapeutic

Phase 1b first-in-patient safety trial for CT1812, a novel Alzheimers synaptic protection therapeutic Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects

BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

2-Hydroxybenzylamine for the prevention of Alzheimers disease: Initial evaluation in humans

2-Hydroxybenzylamine for the prevention of Alzheimers disease: Initial evaluation in humans Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dominantly Inherited Alzheimer Network

Dominantly Inherited Alzheimer Network Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

DIAN-TU: Next Generation Prevention Trial

DIAN-TU: Next Generation Prevention Trial Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment

PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Genomic Characterization of Alzheimers Disease Risk in the Puerto Rican Population

Genomic Characterization of Alzheimers Disease Risk in the Puerto Rican Population Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimers Disease in the Framingham Cohorts

Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimers Disease in the Framingham Cohorts Investments > €500k United States of America Alzheimer’s disease & other dementias 2016